Scientech Research LLC Halozyme Therapeutics, Inc. Transaction History
Scientech Research LLC
- $485 Billion
- Q2 2024
A detailed history of Scientech Research LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 19,839 shares of HALO stock, worth $1.16 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
19,839
Previous 8,214
141.53%
Holding current value
$1.16 Million
Previous $334 Million
210.87%
% of portfolio
0.21%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
517Shares Held
124MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$756 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$341 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$237 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$218 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.18B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...